Skip to content

Study on the efficacy and brain network regulation mechanism of warm-tong cupping in the treatment of acute nonspecific low back pain

Study on the efficacy and brain network regulation mechanism of warm-tong cupping in the treatment of acute nonspecific low back pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000666
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-11-10
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute non-specific low back pain(ANSLBP)

Interventions

Patient Group:One time of warming cupping treatment
Healthy Volunteers Group:Non-intervention
Drug control group:Oral loxoprofen sodium

Sponsors

Tianjin University of Traditional Chinese Medicine Second Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: WTG cupping and medication group: (1) Meets the ANSLBP diagnostic criteria with lower back pain occurring<6 weeks; (2) Age 18-75 years old right-handed; (3) The average Visual Analog Scale (VAS) score for pain in the past week is = 3 points; (4) Not receiving any other relevant treatment for this disease within the past month; (5) No history of intervertebral disc removal surgery or other related surgeries; (6) Voluntarily accept and cooperate with the treatment plan of this study and sign an informed consent form. Healthy control group: (1) Age 18-75 years old right-handed; (2) No history of acute or chronic lower back pain; (3) At least one month prior to enrollment there should be no history of pain caused by any illness and no treatment related to pain has been received; (4) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Suffering from scoliosis ankylosing spondylitis bone tuberculosis tumors severe osteoporosis and other orthopedic diseases or a history of acute pain caused by other diseases in the past month; (2)History of severe spinal trauma and spinal surgery; (3)Contact allergy moxa smoke allergy or loxoprofen sodium tablet allergy; (4)The skin at the operation site is damaged allergic infected etc. which is not suitable for WTG; (5)Individuals with head deformities scalp damage inability to wear headgear or poor fNIRS signals in pre-acquisition; (6)Suffering from autoimmune diseases allergic diseases acute or chronic infectious diseases or serious medical or mental diseases such as cardiovascular hematological and digestive system diseases; (7)Who participated in other clinical research simultaneously in the past week.

Design outcomes

Primary

MeasureTime frame
VAS scores;

Secondary

MeasureTime frame
Erector spinae thickness;HbO2 Mean concentration;Cross sectional area of erector spinae;Joint range of motion ;Pain threshold;MF value of lumbar segment of erector spinae;ß value;Lateralization index;AEMG value of lumbar segment of erector spinae;Functional connectivity;

Countries

China

Contacts

Public ContactYanguo Wang

Tianjin University of Traditional Chinese Medicine Second Affiliated Hospital

tjwangyanguo@163.com+86 137 5205 3466

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026